Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871
V. V. Omelyanovskiy,
E. A. Maksimkina,
O. I. Ivakhnenko,
M. V. Avxentyeva,
M. V. Sura,
G. R. Khachatryan 
Abstract
The article presents a description of amendments of the Russian Federation Government Decree No. 871 from August 28, 2014 (with amendments from November 20, 2018). The authors analyzed the historical development of approaches for complex drug assessment in Russia, also criteria for its evaluation were under investigation. The changes affecting both the order and the procedure of forming the lists of medical drugs for medical use are reviewed. The particularities of the current procedure for the formation of lists of drugs for medical use are described in detail. In reliance on the analysis, further direction for improvement/development of the system of formation the lists of medical drugs for medical use are educed (List of Vital and Essential Medicines, List of Medical Drugs for Certain Categories of Citizens, List of High-Cost Medical Drugs).
About the Authors
V. V. Omelyanovskiy
Center for Healthcare Quality Assessment and Control of the Ministry of Healthcare of the Russian Federation;
Financial Research Institute of the Ministry of Finance of the Russian Federation
Russian Federation
Russian Federation
MD, Dr Sci Med, Professor, General Director; Head of the Center for Healthcare Funding
Researcher ID: P-6911-2018; Scopus Author ID: 6507287753
10-5 Khokhlovsky per., Moscow 109028, Russia
3-2 Nastasyinsky per., Moscow 127006, Russia
E. A. Maksimkina
Department of Drug Supply and Regulation of the circulation of medical devices of the Ministry of Health of the Russian Federation;
Sechenov University
Russian Federation
Russian Federation
MD, Dr Sci (Pharmaceutical Sciences), Professor, Director
3 Rakhmanovskiy per., Moscow 127994, Russia
8-2 Trubetskaya Str., Moscow 119048, Russia
O. I. Ivakhnenko
Center for Healthcare Quality Assessment and Control of the Ministry of Healthcare of the Russian Federation;
Financial Research Institute of the Ministry of Finance of the Russian Federation
Russian Federation
Russian Federation
Deputy Head of the Department of Methodological Support of Comprehensive HTA; Researcher of the Center for Healthcare Funding
Researcher ID: X-4590-2019; Scopus Author ID: 57208723430
10-5 Khokhlovsky per., Moscow 109028, Russia
3-2 Nastasyinsky per., Moscow 127006, Russia
M. V. Avxentyeva
Center for Healthcare Quality Assessment and Control of the Ministry of Healthcare of the Russian Federation;
Financial Research Institute of the Ministry of Finance of the Russian Federation;
Sechenov University
Russian Federation
Russian Federation
MD, Dr Sci Med, Advisor to the Director-General; Leading Research Fellow at the Center of Health Care Finance; Professor at the High School of Health Administration
10-5 Khokhlovsky per., Moscow 109028, Russia
3-2 Nastasyinsky per., Moscow 127006, Russia
8-2 Trubetskaya Str., Moscow 119048, Russia
M. V. Sura
Center for Healthcare Quality Assessment and Control of the Ministry of Healthcare of the Russian Federation;
Russian Presidential Academy of National Economy and Public Administration (RANEPA)
Russian Federation
Russian Federation
MD, PhD, Head of the Scientific and Research Department; Leading Researcher at the Center for HTA, Institute for Applied Economic Research
10-5 Khokhlovsky per., Moscow 109028, Russia
82 Vernadskogo pr., Moscow 119571, Russia
G. R. Khachatryan
Center for Healthcare Quality Assessment and Control of the Ministry of Healthcare of the Russian Federation;
Financial Research Institute of the Ministry of Finance of the Russian Federation;
Russian Presidential Academy of National Economy and Public Administration (RANEPA)
Russian Federation
Russian Federation
Head of the Department of Methodological Support of Comprehensive Health Technology Assessment; Junior Researcher at the Center for Healthcare Funding; Researcher, Laboratory for Technology Assessment in Health Care, Institute of Applied Economic Research
10-5 Khokhlovsky per., Moscow 109028, Russia
3-2 Nastasyinsky per., Moscow 127006, Russia
82 Vernadskogo pr., Moscow 119571, Russia
References
1. Sura M. V., Omelyanovskiy V. V. Evolution of the expertise system for the development of Vital and Essential Drug List. Medical Technologies. Assessment and Choice. 2011; (3): 30–33. (In Russ.)
2. Omelyanovskiy V.V., Sura M.V., Avxentyeva M.V., Khachatryan G.R. The Rules for Creation of Federal Drug Lists: Current State and Development Prospects. Medical Technologies. Assessment and Choice. 2018; (3): 9–17. (In Russ.) DOI: https://doi.org/10.31556/2219-0678.2018.33.3.009-017.
3. Khachatryan G. R., Ivakhnenko О. I., Sura M. V., Avxentyeva М. V. Assessment of the Methodological Quality of Economic Evaluations: Main Mistakes. Medical Technologies. Assessment and Choice. 2019; (1): 8–17. (In Russ.) DOI: https://doi.org/10.31556/2219-0678.2019.35.1.008-017.
4. Ivakhnenko O.I., Khachatryan G.R., Sura M.V., Avxentyeva M.V., Omelyanovskiy V. V. Results of Methodological Quality Assessment of Budget Impact Analysis: Main Mistakes. Medical Technologies. Assessment and Choice. 2018; (4): 11–18. (In Russ.) DOI: https://doi.org/10.31556/2219-0678.2018.34.4.011-018.
Review
For citations:
Omelyanovskiy V.V., Maksimkina E.A., Ivakhnenko O.I., Avxentyeva M.V., Sura M.V., Khachatryan G.R. Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2020;13(2):113-123. (In Russ.) https://doi.org/10.17749/2070-4909/farmakoekonomika.2020.032
Views: 1427
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 